HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shanshan Guo Selected Research

Diabetic Nephropathies (Diabetic Nephropathy)

5/2022Effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on podocytes, inflammation, and oxidative stress in patients with diabetic nephropathy (DN).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shanshan Guo Research Topics

Disease

17Neoplasms (Cancer)
06/2022 - 10/2011
9Infections
08/2021 - 08/2014
7Inflammation (Inflammations)
11/2022 - 12/2015
4Hepatocellular Carcinoma (Hepatoma)
01/2022 - 12/2018
4Body Weight (Weight, Body)
01/2020 - 02/2006
3Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2021
3Necrosis
08/2021 - 02/2006
3Nasopharyngeal Carcinoma
06/2021 - 11/2018
3Colitis
01/2021 - 01/2020
2Carcinogenesis
06/2022 - 01/2021
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2022 - 01/2020
2Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 03/2021
2Neoplasm Metastasis (Metastasis)
06/2021 - 01/2020
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2021 - 01/2018
2Human Influenza (Influenza)
01/2021 - 08/2014
2Vitiligo
01/2021 - 04/2019
2Ulcerative Colitis
01/2020 - 01/2020
2Pain (Aches)
01/2020 - 01/2019
2Iron Overload
12/2018 - 04/2017
2Chronic Obstructive Pulmonary Disease (COPD)
11/2017 - 01/2016
2Colonic Neoplasms (Colon Cancer)
11/2013 - 10/2011
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
06/2022
1Residual Neoplasm
06/2022
1Mitochondrial Diseases (Mitochondrial Disease)
06/2022
1Diabetic Nephropathies (Diabetic Nephropathy)
05/2022
1Carcinosarcoma
01/2022
1Hepatoblastoma
01/2022
1Liver Neoplasms (Liver Cancer)
01/2022
1Melanosis (Freckles)
01/2022
1Neonatal Jaundice
12/2021
1Death (Near-Death Experience)
10/2021
1Muscle Cramp (Cramp)
03/2021
1Urinary Tract Infections (Urinary Tract Infection)
03/2021
1Colitis-Associated Neoplasms
01/2021
1Stroke (Strokes)
01/2021

Drug/Important Bio-Agent (IBA)

9Mitochondrial DNA (mtDNA)IBA
06/2022 - 09/2020
5DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2016
4CytokinesIBA
08/2021 - 01/2018
4Proteins (Proteins, Gene)FDA Link
08/2021 - 01/2011
4Therapeutic UsesIBA
03/2021 - 01/2018
4Messenger RNA (mRNA)IBA
01/2021 - 01/2011
4Pharmaceutical PreparationsIBA
01/2021 - 06/2016
4Antiviral Agents (Antivirals)IBA
01/2020 - 02/2006
3Dextran SulfateIBA
01/2021 - 01/2020
3Biomarkers (Surrogate Marker)IBA
09/2020 - 01/2018
2Transcription Factors (Transcription Factor)IBA
11/2022 - 01/2022
2Triglycerides (Triacylglycerol)IBA
05/2022 - 10/2020
2Polysaccharides (Glycans)IBA
02/2022 - 03/2021
2Interleukin-6 (Interleukin 6)IBA
08/2021 - 01/2021
2Tumor Biomarkers (Tumor Markers)IBA
03/2021 - 12/2016
2Sunitinib (Sutent)FDA Link
01/2021 - 01/2018
2RNA (Ribonucleic Acid)IBA
01/2021 - 12/2016
2Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2019
2geniposideIBA
01/2021 - 01/2016
2Huangqin-TangIBA
01/2020 - 01/2020
2InterferonsIBA
01/2020 - 01/2019
2GlycosidesIBA
01/2020 - 08/2014
2IridoidsIBA
01/2020 - 08/2014
2Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 01/2019
2IronIBA
12/2018 - 01/2018
1Interferon Regulatory FactorsIBA
11/2022
1Histone Deacetylase InhibitorsIBA
06/2022
1N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA
06/2022
1CholesterolIBA
05/2022
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
05/2022
1nephrinIBA
05/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2022
1LiraglutideFDA Link
05/2022
1Hypoglycemic Agents (Hypoglycemics)IBA
05/2022
1Glucagon-Like Peptide-1 ReceptorIBA
05/2022
1Hemoglobins (Hemoglobin)IBA
05/2022
1Malondialdehyde (Propanedial)IBA
05/2022
1podocalyxinIBA
05/2022
1Glutathione PeroxidaseIBA
05/2022
1AlbuminsIBA
05/2022
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
05/2022
1Ethanol (Ethyl Alcohol)IBA
02/2022
1FlavonoidsIBA
02/2022
1Cell-Free Nucleic AcidsIBA
01/2022
1hydrogen sulfite (bisulfite)IBA
01/2022
1BilirubinIBA
12/2021
1dicarboxydine (DCD)IBA
10/2021
1CatalaseIBA
08/2021
1Interleukin-8 (Interleukin 8)IBA
08/2021
1Heme Oxygenase-1IBA
08/2021
1AntioxidantsIBA
08/2021
1NF-kappa B (NF-kB)IBA
08/2021
1Superoxide DismutaseIBA
08/2021
1Emodin (Archin)IBA
08/2021
1Toll-Like Receptors (Toll-Like Receptor)IBA
03/2021
1CathelicidinsIBA
03/2021

Therapy/Procedure

7Therapeutics
01/2022 - 01/2016
4Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021 - 07/2011
2Drug Therapy (Chemotherapy)
02/2022 - 01/2022
2Injections
01/2022 - 07/2011
2Chemoradiotherapy
06/2021 - 11/2018
1Transcutaneous Electric Nerve Stimulation (TENS)
01/2022
1Ischemic Postconditioning
10/2021
1Liver Transplantation
10/2021
1Oral Administration
03/2021